Proficio Capital Partners LLC Supernus Pharmaceuticals, Inc. Transaction History

Proficio Capital Partners LLC

  • $1.19 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 05, 2025
BUY
$31.89 - $37.83 $359,782 - $426,798
11,282 New
11,282 $407,000
Q3 2019

Nov 13, 2019
SELL
$25.47 - $33.37 $2,801 - $3,670
-110 Closed
0 $0
Q2 2019

Aug 13, 2019
BUY
$29.96 - $38.87 $2,606 - $3,381
87 Added 378.26%
110 $4,000
Q1 2019

May 13, 2019
BUY
$32.77 - $41.99 $753 - $965
23 New
23 $1,000

Others Institutions Holding SUPN

# of Institutions
290
Shares Held
60.7M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.05B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Proficio Capital Partners LLC Portfolio

Follow Proficio Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Proficio Capital Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email